Search

everythinglearnresearchcommunity

for

Search:↓

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

1 alpha,25-dihydroxy-vitamin D3 and calcipotriol speed up cell differentiation in hair follicles.

New treatments for lupus show promise, but more research is needed, especially for children.

The treatment slightly increased hair growth and was safe for most women.

Upadacitinib improved multiple immune-related conditions in one patient.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Minoxidil can cause pericardial and pleural effusions with high protein content.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Tofacitinib might be used to treat hair loss.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Minoxidil increases cell layer permeability by reducing tight junction proteins and raising ROS levels.

QLT0267 stops hair follicle cell growth and movement.

Minoxidil works better for female hair loss than alfatradiol, both safe.

Minoxidil can cause hair growth as a side effect.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

The diphosphonate was the most effective at preventing calcification in rats.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Microneedles with Astragalus and minoxidil improve hair growth.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Nanoparticles improve minoxidil skin permeation, but more research needed for effective hair growth.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.